BACKGROUND AND PURPOSE: DIBSGs have the worst prognosis among pediatric brain tumors with no improvement of outcome for several decades. In this study, we determined whether diffusion imaging could improve patient stratification and our understanding of the impact of therapies. MATERIALS AND METHODS: Nine baseline and 24 follow-up DTI studies performed in 9 patients on a 1.5T clinical MR imaging scanner were reviewed. ADC and FA were measured for the whole lesion and at 5 anatomic levels: the rostral medulla, caudal pons, midpons, rostral pons, and caudal midbrain. Reference data were obtained from 8 controls with normal brain stem, 6 patients with medulloblastoma, and 7 patients with pilocytic astrocytoma. RESULTS: ADC was higher in untreated DIBSG than in normal brain stem and medulloblastoma (1.14 ± 0.18 [×10⁻³ mm²/s] versus 0.75 ± 0.06 and 0.56 ± 0.05, both P < .001). FA was lower in DIBSG than in normal brain stem (0.24 ± 0.04 versus 0.43 ± 0.02, P < .001) but was higher than that in pilocytic astrocytoma (0.17 ± 0.05, P < .05). Lower baseline ADC and higher FA correlated with a worse clinical course. Correlations were more significant at the caudal midbrain than in other regions. ADC decreased and FA increased after RT. Changes of FA after RT at the caudal midbrain correlated with event-free survival. CONCLUSIONS: Baseline ADC and FA of DIBSG revealed hypocellular tumors with extensive edema. Diffusion changes after therapy implied reduced edema but did not support a significant response to therapy. The significance of diffusion properties varied with anatomic locations, the caudal midbrain being particularly important.
BACKGROUND AND PURPOSE: DIBSGs have the worst prognosis among pediatric brain tumors with no improvement of outcome for several decades. In this study, we determined whether diffusion imaging could improve patient stratification and our understanding of the impact of therapies. MATERIALS AND METHODS: Nine baseline and 24 follow-up DTI studies performed in 9 patients on a 1.5T clinical MR imaging scanner were reviewed. ADC and FA were measured for the whole lesion and at 5 anatomic levels: the rostral medulla, caudal pons, midpons, rostral pons, and caudal midbrain. Reference data were obtained from 8 controls with normal brain stem, 6 patients with medulloblastoma, and 7 patients with pilocytic astrocytoma. RESULTS: ADC was higher in untreated DIBSG than in normal brain stem and medulloblastoma (1.14 ± 0.18 [×10⁻³ mm²/s] versus 0.75 ± 0.06 and 0.56 ± 0.05, both P < .001). FA was lower in DIBSG than in normal brain stem (0.24 ± 0.04 versus 0.43 ± 0.02, P < .001) but was higher than that in pilocytic astrocytoma (0.17 ± 0.05, P < .05). Lower baseline ADC and higher FA correlated with a worse clinical course. Correlations were more significant at the caudal midbrain than in other regions. ADC decreased and FA increased after RT. Changes of FA after RT at the caudal midbrain correlated with event-free survival. CONCLUSIONS: Baseline ADC and FA of DIBSG revealed hypocellular tumors with extensive edema. Diffusion changes after therapy implied reduced edema but did not support a significant response to therapy. The significance of diffusion properties varied with anatomic locations, the caudal midbrain being particularly important.
Authors: T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi Journal: J Magn Reson Imaging Date: 1999-01 Impact factor: 4.813
Authors: R K Gupta; T F Cloughesy; U Sinha; J Garakian; J Lazareff; G Rubino; L Rubino; D P Becker; H V Vinters; J R Alger Journal: J Neurooncol Date: 2000-12 Impact factor: 4.130
Authors: Anne Laprie; Andrea Pirzkall; Daphne A Haas-Kogan; Soonmee Cha; Anuradha Banerjee; Terry P Le; Ying Lu; Sarah Nelson; Tracy R McKnight Journal: Int J Radiat Oncol Biol Phys Date: 2005-05-01 Impact factor: 7.038
Authors: K J Helton; N S Phillips; R B Khan; F A Boop; R A Sanford; P Zou; C S Li; J W Langston; R J Ogg Journal: AJNR Am J Neuroradiol Date: 2006-04 Impact factor: 3.825
Authors: Ashok Panigrahy; Marvin D Nelson; Jonathan L Finlay; Richard Sposto; Mark D Krieger; Floyd H Gilles; Stefan Blüml Journal: Neuro Oncol Date: 2007-11-14 Impact factor: 12.300
Authors: Rajan Jain; Lisa M Scarpace; Shehanaz Ellika; Roy Torcuator; Lonni R Schultz; David Hearshen; Tom Mikkelsen Journal: J Neurooncol Date: 2009-10-27 Impact factor: 4.130
Authors: Tina Young Poussaint; Sridhar Vajapeyam; Kelsey I Ricci; Ashok Panigrahy; Mehmet Kocak; Larry E Kun; James M Boyett; Ian F Pollack; Maryam Fouladi Journal: Neuro Oncol Date: 2015-10-20 Impact factor: 12.300
Authors: Sanjay P Prabhu; Sarah Ng; Sridhar Vajapeyam; Mark W Kieran; Ian F Pollack; Russell Geyer; Daphne Haas-Kogan; James M Boyett; Larry Kun; Tina Young Poussaint Journal: Childs Nerv Syst Date: 2010-11-04 Impact factor: 1.475
Authors: Katherine A Zukotynski; Frederic H Fahey; Mehmet Kocak; Abass Alavi; Terence Z Wong; S Ted Treves; Barry L Shulkin; Daphne A Haas-Kogan; Jeffrey R Geyer; Sridhar Vajapeyam; James M Boyett; Larry E Kun; Tina Young Poussaint Journal: J Nucl Med Date: 2011-01-13 Impact factor: 10.057
Authors: James L Leach; James Roebker; Austin Schafer; Joshua Baugh; Brooklyn Chaney; Christine Fuller; Maryam Fouladi; Adam Lane; Renee Doughman; Rachid Drissi; Mariko DeWire-Schottmiller; David S Ziegler; Jane E Minturn; Jordan R Hansford; Stacie S Wang; Michelle Monje-Deisseroth; Paul G Fisher; Nicholas G Gottardo; Hetal Dholaria; Roger Packer; Katherine Warren; Sarah E S Leary; Stewart Goldman; Ute Bartels; Cynthia Hawkins; Blaise V Jones Journal: Neuro Oncol Date: 2020-11-26 Impact factor: 12.300
Authors: C Jaimes; S Vajapeyam; D Brown; P-C Kao; C Ma; L Greenspan; N Gupta; L Goumnerova; P Bandopahayay; F Dubois; N F Greenwald; T Zack; O Shapira; R Beroukhim; K L Ligon; S Chi; M W Kieran; K D Wright; T Y Poussaint Journal: AJNR Am J Neuroradiol Date: 2020-05-07 Impact factor: 3.825
Authors: Katherine A Zukotynski; Sridhar Vajapeyam; Frederic H Fahey; Mehmet Kocak; Douglas Brown; Kelsey I Ricci; Arzu Onar-Thomas; Maryam Fouladi; Tina Young Poussaint Journal: J Nucl Med Date: 2017-03-30 Impact factor: 10.057
Authors: Robert M Lober; Yoon-Jae Cho; Yujie Tang; Patrick D Barnes; Michael S Edwards; Hannes Vogel; Paul G Fisher; Michelle Monje; Kristen W Yeom Journal: J Neurooncol Date: 2014-02-13 Impact factor: 4.130
Authors: Matthias W Wagner; W Robert Bell; Jason Kern; Thangamadhan Bosemani; Joyce Mhlanga; Kathryn A Carson; Kenneth J Cohen; Eric H Raabe; Fausto Rodriguez; Thierry A G M Huisman; Andrea Poretti Journal: Eur J Radiol Date: 2016-02-04 Impact factor: 3.528